Immunohistologic c-myc protein in benign breast disease and cancer

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 419-425

  Tulchin, Natalie ^a   Ornstein, Leonard ^a   Bleiweiss, Ira J ^a   Dikman, Steven ^a   Cardiff, Robert D ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

breast disease; c myc protein

Indexed keywords

MYC PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DISEASE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; PRIORITY JOURNAL;

EID: 0029813499     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.3.419     Document Type: Article

References (63)

1. Leder P, Battey J, Lenoir G, Moulding C, Murphy W, Potter H, Stewart T and Taub R: Translocation among antibody genes in human cancer. Science 222: 761-765, 1983.
2. Slamon DJ, DeKernion JB, Verma IM and Cline MJ: Expression of cellular oncogenes in human malignancies. Science 224: 256-264, 1984.
3. Cowley B, Smardo FL, Grantham H and Calvet JP: Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci USA 84: 8394-8398, 1987.
4. Alitalo K, Ramsay G, Bishop JM, Pfeifer SO, Colby WW and Levinson AD: Identification of nuclear proteins encoded by viral and cellular myc oncogenes. Nature 306: 274-277, 1983.
5. Hann SR, Abrams UD, Rohrschneider LR and Eisenman RN: Proteins encoded by v-myc and c-myc oncogenes: identification and localization in acute leukemia virus transformants and bursal lymphoma cell lines. Cell 34: 789-798, 1983.
6. Watt RA, Shatzman AR and Rosenberg M: Expression and characterization of the human c-myc DNA-binding protein. Mol Cell Biol 5: 448-456, 1985.
7. Dani CH, Blanchard JM, Piechazyk M, El Sabouti S, Marty L and Jeanteur PH: Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci USA 81: 7046-7050, 1984.
8. Stewart TA, Pattengale PK and Leder P: Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627-637, 1984.
9. Leder A, Pattengale PK, Kuo A, Stewart TA and Leder P: Consequences of widespread deregulation of the c-myc gene in transgenic mice; multiple neoplasms and normal development. Cell 45: 485-495, 1986.
10. Davis LG, Hennighausen L, Woychik R, Leder A, Tepler I, Kuo A, Stewart TA and Leder P: Breast cancer as a heritable trait in transgenic mice. In: Accomplishments in Cancer Research. Fortner JG (ed). JB Lippincott Co., Philadelphia, pp110-118, 1986.
11. Sinn E, Muller W, Pattengale PK, Tepler I, Wallace R and Leder P: Co-expression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465-475, 1987.
12. Pattengale PK, Stewart TA, Leder A, Sinn E, Muller WJ, Tepler I, Schmidt E and Leder P: Animal models of human disease: pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. Am J Pathol 135: 39-61, 1989.
13. Cardiff RD, Sinn E, Muller W and Leder P: Transgenic oncogene mice: tumor phenotype predicts genotype. Am J Pathol 139: 495-501, 1991.
14. Cardiff RD and Muller WJ: Transgenic mouse models of mammary tumorigenesis. Cancer Surv 16: 97-113, 1993.
15. Andres AC, van der Valk MA, Schonenberger CA, Fluckiger F, LeMeur M, Gerlinger P and Groner B: Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Gene Develop 2: 1486-1495, 1988.
16. Schonenberger CA, Andres AC, Groner B, van der Valk M, LeMeur M and Gerlinger P: Targeted c-myc expression in mammary glands of transgenic mice induces mammary tumors with constitutive milk protein gene transcription. EMBO J 7: 169-175, 1988.
17. Kato GJ and Dang CV: Function of the c-Myc oncoprotein. FASEB J 6: 3065-3072, 1992.
18. Brough DE, Hofmann TJ, Ellwood KB, Townley RA and Cole MD: An essential domain of the c-myc protein interacts with a nuclear factor that is required for E1A-mediated transformation. Mol Cell Biol 15: 1536-1544, 1995.
19. Guerin M, Burrois M, Terrier MJ, Spielmann M and Riou G: Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinoma: correlation with poor prognosis. Oncogene Res 3: 21-31, 1988.
20. Garcia I, Dietrich P-Y, Aapro M, Vauthier G, Vauthier G, Vadas L and Engel E: Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Cancer Res 49: 6675-6679, 1989.
21. Escot C, Theillet C, Lidereau RB, Spyratos F, Champeme M-H, Gest J and Callahan R: Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 83: 4834-4842, 1986.
22. Callahan R and Campbell G: Mutations in human breast cancer: an overview. J Natl Cancer Inst 81: 1780-1786, 1989.
23. Donner P, Greiser-Wilke I and Moelling K: Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature 296: 262-266, 1982.
24. Abrams HD, Rohrschneider LR and Eisenman RN: Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell 29: 427-439, 1982.
25. c-myc as a member of a discrete subset of nuclear proteins. Cell 43: 253-261, 1985.
26. Spector DL, Watt RA and Sullivan NF: The v- and c-myc oncogene proteins colocalize in situ with small nuclear ribonucleoprotein particles. Oncogene 1: 5-12, 1987.
27. Erisman MD, Scott JK, Watt RA and Astrin SM: The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Oncogene 2: 367-378, 1988.
28. Greil R, Fasching B, Weger A and Loidl P: Investigation of nuclear c-myc oncoprotein expression in human hematopoiesis: suitability of a rapid and reliable semiquantitative evaluation system. Lab Invest 62: 251-260, 1992.
29. Jones DJ, Ghosh AK, Moore M and Schofield PF: A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer. Br J Cancer 56: 779-783, 1987.
30. Williams A, Piris J and Wyllie A: Immunohistochemical demonstration of altered intracellular localization of the c-myc oncogene product in human colorectal neoplasms. J Pathol 160: 287-293, 1990.
31. Loke SL, Neckers LM, Schwab G and Jaffe ES: C-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. Am J Pathol 131: 29-37, 1988.
32. Jack AS, Kerr IB, Evan G and Lee FD: The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry. Br J Cancer 53: 713-719, 1986.
33. Stewart J, Evan G, Watson J and Sikora K: Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer 53: 1-6, 1986.
34. Sikora K, Chan S, Evan G, Gabra H, Markham N, Stewart J and Watson J: C-myc oncogene expression in colorectal cancer. Cancer 59: 1289-1295, 1987.
35. Melhem MF, Meisler AI, Finley GG, Bryce WH, Jones MO, Tribby H, Pipas, JM and Koski RA: Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Res 52: 5853-5864, 1992.
36. Tulchin N, Ornstein L, Guillem J, O'Toole K, Lambert M and Weinstein IB: Distribution of the c-myc oncoprotein in normal and neoplastic tissues of the rat colon. Oncogene 3: 697-701, 1988.
37. Tulchin N, Ornstein L, Harpaz N, Guillem J, Borner C and O'Toole K: C-myc protein distribution: neoplastic tissues of the human colon. Am J Pathol 140: 719-729, 1992.
38. Tulchin N, Lee FS, Ornstein L, Strauchen JA and Cardiff RD: c-myc protein distribution: mammary adenocarcinomas of MTV/myc transgenic mice. Int J Oncol 7: 5-9, 1995.
39. Spandidos DA, Pintzas A, Kakkanas A, Yiagnisis M, Mahera H, Patra E and Agnantis NJ: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer Res 7: 1299-1304, 1987.
40. Locker AP, Dowle CS, Ellis IO, Elston CW, Blamey RW, Sikora K, Evan G and Robins RA: C-myc oncogene product expression and prognosis in operable breast cancer. Br J Cancer 60: 669-672, 1989.
41. Pavelic ZP, Pavelic K, Carter CP and Pavelic L: Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast. J Cancer Res Clin Oncol 118: 16-22, 1992.
42. Pietilainen T, Lipponen P, Altomaa S, Eskelinen M, Kosma V-M and Syrjanen K: Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res 15: 959-964, 1995.
43. Association of Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of breast carcinoma. Modern Pathol 9: 77-81, 1996.
44. Sternberger LA, Hardy PH, Cuculis JJ and Meyer HG: The unlabelled antibody enzyme method of immunocytochemistry, preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18: 315-333, 1970.
45. Stein H, Bonk A, Tolkedorf G, Lennert K, Rodt H and Gerdes J: Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem 28: 746-760, 1980.
46. Gerdes J, Schwab U, Lemke H and Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983.
47. Mariani-Constantini R, Escot C, Theillet C, Gentile A, Merlo G, Lidereau R and Callahan R: In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res 48: 199-205, 1988.
48. Dubik D and Shiu RPC: Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594, 1992.
49. Escot C, Simony-Lafontaine J, Maudelonde T, Puech C, Pujol H and Rochefort H: Potential value of increased MYC but not ERBB-2 RNA levels as a marker of high-risk mastopathies. Oncogene 8: 969-974, 1993.
50. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M and Lampertico P: Proliferation index as a prognostic marker in breast cancer. Cancer 71: 3926-3931, 1993.
51. Waitz W and Loidl P: Cell cycle dependent association of c-myc protein with the nuclear matrix. Oncogene 6: 29-35, 1991.
52. Luscher B and Eisenman RN: New light on Myc and Myb. Part I Myc. Gene Develop 4: 2025-2035, 1990.
53. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H: Sequence-specific DNA binding by the c-myc protein. Science 250: 1149-1151, 1990.
54. Halazonetis TD and Kandil AN: Determination of the c-Myc DNA-binding site. Proc Natl Acad Sci USA 88: 6162-6166, 1991.
55. Blackwood EM and Eisenman RN: Max: a Helix-Loop-Helix Zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251: 1211-1217, 1991.
56. Prendergast GC and Ziff EB: Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251: 186-189, 1991.
57. Stone J, de Lange T, Ramsay G, Jakobovits E, Bishop JM, Varmus H and Lee W: Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol 7: 1697-1709, 1987.
58. Sarid J, Halazonetis TD, Murphy W and Leder P: Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc Natl Acad Sci USA 84: 170-173, 1987.
59. Dang CV and Lee W: Identification of the human c-myc protein nuclear translocation signal. Mol Cell Biol 8: 4048-4054, 1988.
60. Evan GI, Lewis G, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992.
61. Kelly K, Cochran BH, Stiles CD and Leder P: Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603-610, 1983.
62. Moll UM, Riou G and Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89: 7262-7266, 1992.
63. Chen Y, Chen C-F, Riley DJ, Allred C, Chen P-L, Von Hoff D, Osborne CK and Lee W-H: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.